Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 619

1.

Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.

Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.

J Ren Care. 2008 Sep;34(3):112-5. doi: 10.1111/j.1755-6686.2008.00026.x.

PMID:
18786076
2.

Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.

Mircescu G, Gârneata L, Capusa C, Ursea N.

Nephrol Dial Transplant. 2006 Jan;21(1):120-4.

3.

Iron supplementation in haemodialysis--practical clinical guidelines.

Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.

Nephrol Dial Transplant. 1998 Oct;13(10):2572-7.

4.

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.

Lyseng-Williamson KA, Keating GM.

Drugs. 2009;69(6):739-56. doi: 10.2165/00003495-200969060-00007. Review.

PMID:
19405553
5.
6.

Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.

Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A.

Perit Dial Int. 2002 Jan-Feb;22(1):60-6.

7.

Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?

Dukkipati R, Kalantar-Zadeh K.

Nephrol News Issues. 2007 Jan;21(1):34-8. Review.

PMID:
17269263
8.

[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].

Li H, Wang SX.

Zhonghua Yi Xue Za Zhi. 2009 Feb 24;89(7):457-62. Chinese.

PMID:
19567093
9.
10.

Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.

Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M.

Am J Kidney Dis. 1996 Feb;27(2):234-8.

PMID:
8659499
11.

[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].

Fesiuk AF, Mordik AI, Borisova EV, Borisov AV, Lovchinskiĭ EV.

Ter Arkh. 2003;75(8):59-61. Russian.

PMID:
14520854
13.

Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.

Ferrari P, Mallon D, Trinder D, Olynyk JK.

Nephrology (Carlton). 2010 Apr;15(3):344-9. doi: 10.1111/j.1440-1797.2009.01203.x.

PMID:
20470305
14.
15.

Clinical review of the newer intravenous iron therapy options.

Edwards JH.

Nephrol Nurs J. 2003 Feb;30(1):70-3. Review.

PMID:
12674953
16.

Intravenous iron sucrose in peritoneal dialysis patients with renal anemia.

Li H, Wang SX.

Perit Dial Int. 2008 Mar-Apr;28(2):149-54.

17.
19.

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.

Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB.

Am J Kidney Dis. 2001 Feb;37(2):300-7.

PMID:
11157370
20.

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.

Szczech LA, Bregman DB, Harrington RA, Morris D, Butcher A, Koch TA, Goodnough LT, Wolf M, Onken JE.

Nephrol Dial Transplant. 2010 Jul;25(7):2368-75. doi: 10.1093/ndt/gfq218.

Items per page

Supplemental Content

Support Center